LEGACY VENTURES INTERNATIONAL INC. (LGYV) Financial Statements (2025 and earlier)

Company Profile

Business Address 27 BAYCLIFFE RD.
MARKHAM, ON L3R 7T9
State of Incorp. NV
Fiscal Year End June 30
Industry (SIC) 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) (USD)

9/30/2024
MRQ
6/30/2024
6/30/2023
6/30/2022
6/30/2021
6/30/2020
6/30/2019
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments8421,67821,01722,78015,13612,745
Cash and cash equivalent8421,67821,01722,78015,13612,745
Prepaid expense  509    
Total current assets:8422,18721,01722,78015,13612,745
Noncurrent Assets
TOTAL ASSETS:8422,18721,01722,78015,13612,745
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:31,90438,60220,248140,609116,09792,764
Interest and dividends payable 32,41811,8943,651
Other undisclosed accounts payable and accrued liabilities31,90438,60220,248108,191104,20389,113
Debt    185,000120,00070,000
Due to related parties 11,47337,67522,92522,925
Other undisclosed current liabilities     11,894 
Total current liabilities:31,90438,60231,721363,284270,916185,689
Noncurrent Liabilities
Other undisclosed liabilities105,80736,168 17,668 3,651
Total liabilities:137,71174,77031,721380,952270,916189,340
Equity
Equity, attributable to parent(136,869)(72,583)(10,704)(358,172)(255,780)(176,595)
Common stock5,0325,0325,032323232
Additional paid in capital6,429,7716,429,7716,429,7716,394,7716,394,7716,394,771
Accumulated deficit(6,571,672)(6,507,386)(6,445,507)(6,752,975)(6,650,583)(6,571,398)
Total equity:(136,869)(72,583)(10,704)(358,172)(255,780)(176,595)
TOTAL LIABILITIES AND EQUITY:8422,18721,01722,78015,13612,745

Income Statement (P&L) (USD)

9/30/2024
TTM
6/30/2024
6/30/2023
6/30/2022
6/30/2021
6/30/2020
6/30/2019
Operating expenses(64,291)(61,943)(54,822)(5,264)(8,863)(10,347)
Other undisclosed operating loss    (46,900)(50,410)(50,850)
Operating loss:(64,291)(61,943)(54,822)(52,164)(59,273)(61,197)
Nonoperating income (expense)564362,290(50,228)(29,912)26,353
Gain, foreign currency transaction, before tax5229145   
Interest and debt expense   (13,363)(20,524)(8,243)(31,622)
Income (loss) from continuing operations before equity method investments, income taxes:(64,286)(61,879)294,105(122,916)(97,428)(66,466)
Other undisclosed income from continuing operations before income taxes   13,36320,5248,24331,622
Income (loss) from continuing operations:(64,286)(61,879)307,468(102,392)(89,185)(34,844)
Income (loss) before gain (loss) on sale of properties:307,468(102,392)(89,185)(34,844)
Net income (loss) available to common stockholders, diluted:(64,286)(61,879)307,468(102,392)(89,185)(34,844)

Comprehensive Income (USD)

9/30/2024
TTM
6/30/2024
6/30/2023
6/30/2022
6/30/2021
6/30/2020
6/30/2019
Net income (loss):(64,286)(61,879)307,468(102,392)(89,185)(34,844)
Comprehensive income (loss), net of tax, attributable to parent:(64,286)(61,879)307,468(102,392)(89,185)(34,844)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: